Skip to content Skip to footer
Subscribe Now

SPOTLIGHT

Spotlight Interview_Philippe Barillon
Reuters Pharma 2025: Pre-Conference Talks Featuring Philippe Barillon
Philippe Barillon joins PharmaShots Managing Editor Himanshu Sehgal for an enlightening dialogue exchange in a Pre-Conference Talk.Philippe will be joining the upcoming Reuters Events Pharma 2025 as a panelist for the topic “Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and market growth”.Philippe highlights the potential applications of RWEs using…
April 7, 2025
Spotlight Interview_Konrad Dobschuetz
Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad Dobschuetz
Konrad Dobschuetz, Founder Director at Leap Advisory & Intelligence will be conducting a workshop at the upcoming Reuters Events Pharma 2025 on the topic “Patient Centricity”. In the exclusive discussion with PharmaShots, Konrad addresses the need for biopharma companies to achieve a patient mindset to deliver patient-centric care and enhance the patient experience.Konrad believes…
April 4, 2025
Spotlight Interview_Vikram Mohan
Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram Mohan
Vikram Mohan will be joining the upcoming Pharma 2025 event as a panelist with the Topic “Content’s Industrial Revolution”. Vikram believes that with a paradigm shift from the traditional approach to creating, approving, reviewing, and deploying content in the evolving biopharma industry, there’s room for generative AI to act as an assistant to make the…
April 2, 2025
Spotlight Interview_Rahul Mittal
Reuters Pharma USA 2025: Post-Conference Talks featuring Rahul Mittal
Brimming with insightful panel discussions, presentations on disruptive technologies, and illuminating real-world evidence shaping the healthcare landscape now and then, the two-day Reuters event celebrated pharmaceutical innovation and fresh perspectives pouring into the interactive sessions.In the panel discussion at Reuters Pharma USA 2025, Rahul Mittal outlined ways to enhance patient centricity and engagement. Rahul…
March 31, 2025
Spotlight Interview_Heba Nowyhed
CXO Talks: Heba Nowyhed from Arcellx in a Candid Conversation with PharmaShots
CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel. During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…
March 28, 2025
Spotlight Interview_T.J.Sharpe
Reuters Pharma USA 2025: Pre Conference Talks featuring T.J. Sharpe
With breakthrough discoveries addressing patients' unmet needs, caregivers, decision-makers, and advocacy groups have made great strides towards bringing patient experience to the mainstream. Today's guest is TJ Sharpe, a Patient Insights Expert and Stage-IV Melanoma survivor. In his topic "Complicating is easy, Simplifying is Difficult, the personalized patient experience", T.J. will shed light on patient…
March 13, 2025
Spotlight Interview_Cary Claiborne
CXO Talks: Cary Claiborne from Adial Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots
Welcome to the sixth episode of CXO Talks, featuring Cary Claiborne, CEO of Adial Pharmaceuticals a clinical-stage biopharmaceutical company dedicated to developing therapies for the treatment and prevention of addiction and related disorders. Taking a walk down memory lane, Cary shares the inspiration behind founding Adial Pharmaceuticals. He recounts how an early study at the…
December 9, 2024
Spotlight Interview_Rashmi Gurnani
CXO Talks: Rashmi Gurnani from AKT Health Analytics in a Riveting Dialogue Exchange with PharmaShots
In the fourth reprise of our recently launched Complimentary Exclusive Video Interview, we have Rashmi Gurnani CEO of AKT Health Analytics. Rashmi sheds light on AKT’s distributor partnership with Certara, known for delivering global drug development solutions to pharmaceutical companies and CROs. While discussing AKT’s role in assisting the US clients with Japan’s PMDA’s approval,…
October 14, 2024
Spotlight Interview_Jonathan Usuka
CXO Talks: Jonathan Usuka Chief Business Officer at Sapient, in a Stimulating Conversation with PharmaShots
Introducing the third installment of our recently launched Complimentary Exclusive Video Interview. Jonathan Usuka, Chief Business Officer at Sapient, highlighted Sapient’s high throughput proteomics and metabolomics capabilities to generate multi-omics data and the analytical power to transcend the genome to achieve robust biological discoveries in expediting clinical studies.By leveraging Sapient's real-world data asset, the…
September 9, 2024
Load more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]